Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Zappulo

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Le Infezioni in Medicina|March 22, 2014
Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Review of Anti-Infective Therapy|February 9, 2018
Management of chronic viral hepatitis in the hematological patientLaura Ambra Nicolini, Emanuela Zappulo, Claudio Viscoli, et al.
Expert Review of Clinical Pharmacology|July 25, 2022
Pharmacological approaches to prevent vertical transmission of HIV and HBVEmanuela Zappulo, Agnese Giaccone, Nicola Schiano Moriello, et al.
Expert Opinion on Investigational Drugs|November 12, 2014
Discontinued drugs in 2012 - 2013: hepatitis C virus infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Review of Anti-Infective Therapy|May 21, 2014
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virusIvan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.
Expert Review of Anti-Infective Therapy|June 12, 2014
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
European Journal of Internal Medicine|September 19, 2017
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stageIvan Gentile, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Expert Opinion on Drug Safety|September 3, 2015
Asunaprevir for hepatitis C: a safety evaluationIvan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.
Expert Review of Anti-Infective Therapy|August 7, 2014
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Opinion on Investigational Drugs|May 23, 2014
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virusIvan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Le Infezioni in Medicina|March 22, 2014
Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Review of Anti-Infective Therapy|February 9, 2018
Management of chronic viral hepatitis in the hematological patientLaura Ambra Nicolini, Emanuela Zappulo, Claudio Viscoli, et al.
Expert Review of Clinical Pharmacology|July 25, 2022
Pharmacological approaches to prevent vertical transmission of HIV and HBVEmanuela Zappulo, Agnese Giaccone, Nicola Schiano Moriello, et al.
Expert Opinion on Investigational Drugs|November 12, 2014
Discontinued drugs in 2012 - 2013: hepatitis C virus infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Review of Anti-Infective Therapy|May 21, 2014
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virusIvan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.
Expert Review of Anti-Infective Therapy|June 12, 2014
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
European Journal of Internal Medicine|September 19, 2017
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stageIvan Gentile, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Expert Opinion on Drug Safety|September 3, 2015
Asunaprevir for hepatitis C: a safety evaluationIvan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.
Expert Review of Anti-Infective Therapy|August 7, 2014
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infectionIvan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, et al.
Expert Opinion on Investigational Drugs|May 23, 2014
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virusIvan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, et al.
Pageof 8